US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 9.310
  • -0.020-0.21%
Close Nov 29 13:00 ET
  • 9.300
  • -0.010-0.11%
Post 17:01 ET
907.41MMarket Cap-14777P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Poseida Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.500M--
--2024/Q4-- / 21.250M--
--2024/Q371.748M / 16.250M--
--2024/Q225.973M / 15.417M--
--2024/Q128.142M / 11.667M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.500M--
--2024/Q4-- / 21.250M--
--2024/Q371.748M / 16.250M--
--2024/Q225.973M / 15.417M--
--2024/Q128.142M / 11.667M--

Unlock Free Earnings Estimates

Poseida Therapeutics Earnings Reports

  • Poseida Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:18 ET

  • Poseida Therapeutics | 8-K: Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024

    Nov 7 16:14 ET

  • Poseida Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:15 ET

  • Poseida Therapeutics | 8-K: Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024

    Aug 5 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Hold

    • Buy

      20.00%

    • Hold

      80.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data